In addition, compelling evidence suggests that human MutL Homolog 1 (hMLH1) and human MutS Homolog 2 (hMSH2) are closely associated with the development and drug resistance of cancer (Xing et al., 2019). The gene discussed is MSH2; the disease is cancer.